Introducción: Los recién nacidos prematuros extremos (< 32 semanas de edad gestacional, EG) son una población de riesgo para desarrollar infecciones invasivas y sufrir complicaciones derivadas de la respuesta inflamatoria asociadas. Por otra parte representan un modelo interesante para generar conocimientos sobre la importancia del sistema...
-
November 26, 2015 (v1)PublicationUploaded on: March 27, 2023
-
September 26, 2023 (v1)Publication
Inborn errors of immunity are a heterogeneous group of genetically determined disorders that compromise the immune system, predisposing patients to infections, autoinflammatory/autoimmunity syndromes, atopy/allergies, lymphoproliferative disorders, and/or malignancies. An emerging manifestation is susceptibility to fungal disease, caused by...
Uploaded on: October 11, 2023 -
October 26, 2022 (v1)Publication
Background Inborn errors of immunity (IEI) are rare diseases, which makes diagnosis a challenge. A better description of the initial presenting manifestations should improve awareness and avoid diagnostic delay. Although increased infection susceptibility is a well-known initial IEI manifestation, less is known about the frequency of other...
Uploaded on: March 24, 2023 -
October 16, 2024 (v1)Publication
El tratamiento actualmente recomendado para la Leishmaniasis visceral por L. infantum es Anfotericina B liposomal (ABL), a una dosis de 4 mg/kg durante 5 días consecutivos y una dosis de recuerdo al décimo día. Este tratamiento presenta baja toxicidad, alta eficacia y costes más bajos en comparación con otros fármacos debido a estancias...
Uploaded on: October 17, 2024 -
December 15, 2022 (v1)Publication
Purpose STAT1 gain-of-function (GOF) and dominant-negative (DN) STAT3 syndromes share clinical manifestations includ ing infectious and infammatory manifestations. Targeted treatment with Janus-kinase (JAK) inhibitors shows promising results in treating STAT1 GOF-associated symptoms while management of DN STAT3 patients has been largely...
Uploaded on: March 24, 2023 -
November 16, 2022 (v1)Publication
Introduction Since the frst description of gain of function (GOF) mutations in signal transducer and activator of transcrip tion (STAT) 1, more than 300 patients have been described with a broad clinical phenotype including infections and severe immune dysregulation. Whilst Jak inhibitors (JAKinibs) have demonstrated benefts in several...
Uploaded on: December 4, 2022 -
June 2, 2023 (v1)Publication
SARS-CoV-2 infection has become a global health problem specially exacerbated with the continuous appearance of new variants. Healthcare workers (HCW) have been one of the most affected sectors. Children have also been affected, and although infection generally presents as a mild disease, some have developed the Pediatric Inflammatory...
Uploaded on: June 3, 2023 -
September 26, 2022 (v1)Publication
Primary immune regulatory disorders (PIRD) are associated with autoimmunity, autoinflammation and/or dysregulation of lymphocyte homeostasis. Autoimmune lymphoproliferative syndrome (ALPS) is a PIRD due to an apoptotic defect in Fas-FasL pathway and characterized by benign and chronic lymphoproliferation, autoimmunity and increased risk of...
Uploaded on: December 4, 2022 -
December 5, 2022 (v1)Publication
Objective: To evaluate the efficacy of colchicine therapy in pediatric patients with PFAPA syndrome who present with an incomplete response to the standard treatment or with frequent episodes (an interval of less than 14 days between two disease flares). Methods: A multicenter cohort study of children diagnosed with PFAPA syndrome and treated...
Uploaded on: February 22, 2023 -
January 18, 2018 (v1)Publication
Background: Quantification of T-cell-receptor-excision circles (TRECs) and kappa-deleting-recombination-excision circles (KRECs) from dried blood spots (DBS) allows detection of neonates with severe T-cell and/or B-cell lymphopenia that are potentially affected by severe combined immunodeficiency (SCID), as well as X-linked agammaglobulinemia...
Uploaded on: March 27, 2023 -
March 31, 2023 (v1)Publication
The COVID-19 pandemic represents a valuable opportunity to carry out cohort studies that allow us to advance our knowledge on pathophysiological mechanisms of neuropsychiatric diseases. One of these opportunities is the study of the relationships between inflammation, brain development and an increased risk of suffering neuropsychiatric...
Uploaded on: April 14, 2023